uric acid has been researched along with Infections in 28 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
Excerpt | Relevance | Reference |
---|---|---|
"The lower levels of serum uric acid (UA) correlated with meningitis have been reported." | 7.83 | Serum uric acid levels in patients with infections of central nervous system. ( Li, M; Liu, J; Peng, FH; Wang, X; Xu, L; Yi, H; Zhong, XF, 2016) |
"In a study of 40 children with kwashiorkor, serum albumin, transferrin, and immunoglobulin levels were measured." | 7.65 | Immunity, transferrin, and survival in kwashiorkor. ( Adcock, KJ; Adeshina, H; Akene, J; Cooke, AR; McFAarlane, H; Reddy, S, 1970) |
"The lower levels of serum uric acid (UA) correlated with meningitis have been reported." | 3.83 | Serum uric acid levels in patients with infections of central nervous system. ( Li, M; Liu, J; Peng, FH; Wang, X; Xu, L; Yi, H; Zhong, XF, 2016) |
"Val142Leu) in PRPS1 in a patient with uric acid overproduction without gout but with developmental delay, hypotonia, hearing loss, and recurrent respiratory infections." | 3.78 | Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I. ( Christodoulou, J; de Brouwer, AP; Duley, J; Friedman, NR; Kuilenburg, AB; Moran, R; Nabuurs, SB; Retno-Fitri, A; Roelofsen, J; van Bokhoven, H; Yntema, HG, 2012) |
"These data indicate that lactic acidosis does not entirely account for the metabolic acidosis during severe sepsis." | 3.68 | Unaccounted for anion in metabolic acidosis during severe sepsis in humans. ( Astiz, ME; Mecher, C; Rackow, EC; Weil, MH, 1991) |
"In a study of 40 children with kwashiorkor, serum albumin, transferrin, and immunoglobulin levels were measured." | 3.65 | Immunity, transferrin, and survival in kwashiorkor. ( Adcock, KJ; Adeshina, H; Akene, J; Cooke, AR; McFAarlane, H; Reddy, S, 1970) |
"Urinary tract infections (UTIs) were detected in 65." | 1.39 | Urinary stone disease in the first year of life: is it dangerous? ( Alpay, H; Bıyıklı, N; Gokce, I; Özen, A, 2013) |
"Although increased susceptibility to infection has been observed in subjects with diabetes or obesity, little is known about the relationship between metabolic disorders and increased susceptibility to infection." | 1.36 | Association between capacity of interferon-alpha production and metabolic parameters. ( Fukui, M; Hasegawa, G; Nakamura, N; Nakumura, N; Tominaga, M; Uno, K; Yagi, K; Yoshikawa, T, 2010) |
"Gestational age, endotracheal infection, and septicaemia had good predictive power." | 1.32 | Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. ( Collard, KJ; Godeck, S; Holley, JE; Quinn, MW, 2004) |
"In the first week, infection contributed to 71% of the deaths and pulmonary hemorrhage associated with diffuse alveolar damage contributed to 44%; the incidence of infection rose while the incidence of hemorrhage decreased during weeks 2 to 4." | 1.31 | Reducing mortality associated with immediate treatment complications of adult leukemias. ( Estey, E, 2001) |
" The importance of dosage schedule for remission maintenance chemotherapy is stressed." | 1.25 | The management of acute leukemia. ( Freireich, EJ, 1967) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (60.71) | 18.7374 |
1990's | 2 (7.14) | 18.2507 |
2000's | 4 (14.29) | 29.6817 |
2010's | 5 (17.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heppner, HJ | 1 |
Liu, J | 1 |
Li, M | 1 |
Wang, X | 1 |
Yi, H | 1 |
Xu, L | 1 |
Zhong, XF | 1 |
Peng, FH | 1 |
Tominaga, M | 1 |
Uno, K | 1 |
Yagi, K | 1 |
Fukui, M | 1 |
Hasegawa, G | 1 |
Yoshikawa, T | 1 |
Nakamura, N | 1 |
Nakumura, N | 1 |
Moran, R | 1 |
Kuilenburg, AB | 1 |
Duley, J | 1 |
Nabuurs, SB | 1 |
Retno-Fitri, A | 1 |
Christodoulou, J | 1 |
Roelofsen, J | 1 |
Yntema, HG | 1 |
Friedman, NR | 1 |
van Bokhoven, H | 1 |
de Brouwer, AP | 1 |
Alpay, H | 1 |
Gokce, I | 1 |
Özen, A | 1 |
Bıyıklı, N | 1 |
Giapros, VI | 2 |
Andronikou, SK | 1 |
Cholevas, VI | 2 |
Papadopoulou, ZL | 2 |
FERNANDEZDELVALLADO, P | 1 |
GIJONBANOS, J | 1 |
BELTRANGUTIERREZ, J | 1 |
GARCIASORO, JM | 1 |
Collard, KJ | 1 |
Godeck, S | 1 |
Holley, JE | 1 |
Quinn, MW | 1 |
Rajtar, R | 1 |
Kloch, M | 1 |
Bober, M | 1 |
Kolasińska-Kloch, W | 1 |
Freireich, EJ | 1 |
Kobrinsky, NL | 1 |
Robison, LL | 1 |
Nesbit, ME | 1 |
Andronikou, S | 1 |
Estey, E | 1 |
Pochedly, C | 1 |
Mecher, C | 1 |
Rackow, EC | 1 |
Astiz, ME | 1 |
Weil, MH | 1 |
Najarian, JS | 1 |
Fryd, DS | 1 |
Strand, M | 1 |
Canafax, DM | 1 |
Ascher, NL | 1 |
Payne, WD | 1 |
Simmons, RL | 1 |
Sutherland, DE | 1 |
Reddy, S | 1 |
Adcock, KJ | 1 |
Adeshina, H | 1 |
Cooke, AR | 1 |
Akene, J | 1 |
McFAarlane, H | 1 |
Burr, IM | 1 |
O'Neill, JA | 1 |
Karzon, DT | 1 |
Howard, LJ | 1 |
Greene, HL | 1 |
Sonntag, RW | 1 |
Knott, DH | 1 |
Fink, RD | 1 |
Beard, JD | 1 |
Tiso, B | 1 |
Herrlein, A | 1 |
Ward, HP | 1 |
Block, MH | 1 |
Smith, LH | 1 |
Nahlovsky, J | 1 |
Farhat, M | 1 |
Gharbi, S | 1 |
Isomäki, H | 1 |
Rautenstrauch, H | 1 |
Norcross, JW | 1 |
Borgno, M | 1 |
Marten Perolino, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Strong Ion Gap as Prognostic Indicator for Adult Patients Admitted With Shock to the Intensive Care Units[NCT02652364] | 112 participants (Actual) | Observational | 2015-10-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for uric acid and Infections
Article | Year |
---|---|
[The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
Topics: Animals; Atherosclerosis; Biomarkers; Causality; Clinical Trials as Topic; Comorbidity; Fibrin Fibri | 2006 |
Acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Agranulocytosis; Antineoplastic Agents; Cells, Cultured; Child; Child, Pr | 1980 |
The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Topics: Adrenal Cortex Hormones; Alkaline Phosphatase; Androgens; Anemia; Animals; Blood Cell Count; Blood C | 1971 |
2 trials available for uric acid and Infections
Article | Year |
---|---|
Renal function in premature infants during aminoglycoside therapy.
Topics: Amikacin; Calcium; Case-Control Studies; Creatinine; Gentamicins; Humans; Infant, Newborn; Infant, P | 1995 |
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Aspartate Aminotransferases; Azathioprine; Clinical Trials | 1985 |
23 other studies available for uric acid and Infections
Article | Year |
---|---|
Topics: Cohort Studies; Gout; Humans; Immune System; Infections; Uric Acid | 2018 |
Serum uric acid levels in patients with infections of central nervous system.
Topics: Adult; Aged; Antioxidants; Central Nervous System; Female; Humans; Infections; Male; Meningitis; Mid | 2016 |
Association between capacity of interferon-alpha production and metabolic parameters.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Disease Susceptibility; Female; Humans; Hyperglycemia; | 2010 |
Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I.
Topics: Ataxia; Child, Preschool; Deaf-Blind Disorders; Enzyme Activation; Genetic Diseases, X-Linked; Genet | 2012 |
Urinary stone disease in the first year of life: is it dangerous?
Topics: Cholelithiasis; Citrates; Cystic Fibrosis; Cystinuria; Epilepsy; Female; Genetic Predisposition to D | 2013 |
Renal function and effect of aminoglycoside therapy during the first ten days of life.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Gentamicins; Humans; Infant, Newborn; Infant, Prem | 2003 |
[ANKYLOSING SPONDYLITIS. ETIOLOGICAL CONSIDERATIONS AND CLINICAL ASPECTS].
Topics: Arthritis; Arthritis, Rheumatoid; Blood Protein Electrophoresis; Blood Sedimentation; C-Reactive Pro | 1964 |
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies.
Topics: Aging; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cohort | 2004 |
The management of acute leukemia.
Topics: Adult; Anti-Bacterial Agents; Child; Cyclophosphamide; Hemorrhage; Humans; Infections; Leukemia, Lym | 1967 |
Reducing mortality associated with immediate treatment complications of adult leukemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cause of Death; Humans; Infection | 2001 |
Supportive therapy for the leukemic patient in acute relapse.
Topics: Acute Disease; Blood Transfusion; Humans; Infections; Leukemia; Platelet Transfusion; Thrombocytopen | 1977 |
Unaccounted for anion in metabolic acidosis during severe sepsis in humans.
Topics: Acid-Base Equilibrium; Acidosis; Adult; Aged; Aged, 80 and over; Anions; Blood Proteins; Creatine; F | 1991 |
Immunity, transferrin, and survival in kwashiorkor.
Topics: Child, Preschool; Chloroquine; Diet Therapy; Dietary Proteins; Female; Folic Acid; gamma-Globulins; | 1970 |
Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
Topics: Adolescent; Amino Acids; Enteral Nutrition; Glucose; Glycogen Storage Disease; Hepatomegaly; Humans; | 1974 |
[General medical measures in neoplastic diseases and their complications].
Topics: Anemia; Central Nervous System Diseases; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism | 1967 |
Unmasking alcohol abuse.
Topics: Alcoholism; Blood Pressure; Carbohydrate Metabolism; Gastrointestinal Diseases; Heart; Humans; Infec | 1974 |
[The aetiology of myocardial infarction in young people (author's transl)].
Topics: Adult; Age Factors; Contraceptives, Oral; Female; Humans; Infections; Male; Metabolic Diseases; Myoc | 1973 |
Nephrolithiasis. Current concepts in pathogenesis and management.
Topics: Acidosis, Renal Tubular; Citrates; Cystinuria; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentrati | 1972 |
[Extraordinary incidence of lithiasis in children in Tunisia and their probable causes].
Topics: Age Factors; Child; Child, Preschool; Female; Humans; Infant; Infections; Male; Nutrition Disorders; | 1969 |
Hyperuricaemia in northern Finland. An epidemiological study of serum uric acid in rural, urban and hospital populations.
Topics: Adolescent; Adult; Age Factors; Aged; Anemia; Body Weight; Cerebrovascular Disorders; Cholesterol; C | 1969 |
[Duration of disease and survival time in plasmacytoma].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Antineoplastic Agents; Blood Urea Nitrogen; Cyclo | 1970 |
Chronic lymphatic leukemia in the older patient.
Topics: Aged; Anemia; Chlorambucil; Diagnosis, Differential; Humans; Infections; Leukemia, Lymphoid; Lymphat | 1968 |
[Notes on etiopathogenesis and current trends of medical treatment of renal lithiasis].
Topics: Amino Acids; Calcium Metabolism Disorders; Carbohydrate Metabolism; Diet Therapy; Drug Therapy; Huma | 1969 |